We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
12
1 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
N/A
Completed
6
50.0%
Not yet recruiting
1
8.3%
Recruiting
5
41.7%
No approval data available
- BGI Group marked its 27th anniversary with a Shenzhen launch event presenting technologies spanning brain science, multi-omics diagnostics, active health management, nutrition, skincare, pet health and soil ecology. - BGI Genomics introduced a Digital Life Twin framework that cross-references routine annual checkup metrics with population-level data from large healthy cohorts to build individual baseline profiles. - The company unveiled a multimodal brain-on-chip system integrating on-chip neuronal and brain organoid culture with electrophysiological and optical interaction for neurological disease modeling and neuropharmacological screening. - BGI also presented the upgraded i99 Smart Health platform, the two-square-meter i3 Smart Cabin terminal, and expanded WGLIFE and BIOAGE molecular aging testing portfolios.